A 20-year follow-up evaluation of total hip arthroplasty in patients younger than 50 using a custom cementless stem.


Journal

Hip international : the journal of clinical and experimental research on hip pathology and therapy
ISSN: 1724-6067
Titre abrégé: Hip Int
Pays: United States
ID NLM: 9200413

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 24 10 2018
medline: 30 11 2019
entrez: 24 10 2018
Statut: ppublish

Résumé

The purpose of this study is to report the 20-year follow-up of a continuous series of 232 total hip arthroplasties (THAs) performed in patients aged less than 50 at the index surgery. This is a retrospective monocentric study which reports the clinical, radiographical and survival results of 232 THAs performed with a custom cementless femoral stem in 212 patients evaluated at follow-up ranging from 14 to 27 years. At the time of follow-up, the mean Harris Hip Score was 94.1 (range 48-100). The Hip disability and Osteoarthritis Outcome Score was >80 points in all 5 categories for 146 patients (68.9%). 18 hips (8.5%) showed radiographical femoral abnormalities. 23 hips (10.8%) underwent revision of the implants. 13 were isolated cup revisions. 3 more hips had bipolar revisions for aseptic loosening at 15, 20 and 21 years. Taking stem revision for aseptic loosening as an endpoint, survivorship was 96.8% at 20 years (95% confidence interval, 95.1-98.5; patients at risk 76) and 94.5% at 25 years (91.7-97.3; patients at risk 12). The results of this study confirm that THA using this custom-designed stem can provide excellent clinical and radiographical outcomes at a mean follow-up of 20 years in patients younger than 50. The individual 3D femoral stem and prosthetic neck has been able to restore extra- and intramedullary functional anatomy in this young and active cohort of patients.

Identifiants

pubmed: 30350719
doi: 10.1177/1120700018803290
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-488

Auteurs

Edouard Dessyn (E)

The Institute of Movement and Locomotion, Department of Orthopaedics and Traumatology, St Marguerite Hospital, Marseille, France.

Xavier Flecher (X)

The Institute of Movement and Locomotion, Department of Orthopaedics and Traumatology, St Marguerite Hospital, Marseille, France.

Sebastien Parratte (S)

The Institute of Movement and Locomotion, Department of Orthopaedics and Traumatology, St Marguerite Hospital, Marseille, France.

Matthieu Ollivier (M)

The Institute of Movement and Locomotion, Department of Orthopaedics and Traumatology, St Marguerite Hospital, Marseille, France.

Jean-Noël Argenson (JN)

The Institute of Movement and Locomotion, Department of Orthopaedics and Traumatology, St Marguerite Hospital, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH